Picture of CRISM Therapeutics logo

CRTX CRISM Therapeutics Balance Sheet

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for CRISM Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
fx
Final
fx
Final
Final
Cash
Cash and Short Term Investments2.044.942.883.441.28
Net Total Receivables0.0040.08100.05
Total Inventory
Prepaid Expenses
Total Current Assets2.315.022.933.761.69
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment17.500.052
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets23.723.123.83.761.82
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.6680.7150.6160.520.341
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.7710.8330.7610.520.341
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity22.922.3233.241.48
Total Liabilities & Shareholders' Equity23.723.123.83.761.82
Total Common Shares Outstanding